Stockscreener 앱 받기
16.50
1.20%
-0.215
전일 마감가:
$16.72
열려 있는:
$17.06
하루 거래량:
102.63K
Relative Volume:
0.24
시가총액:
$886.52M
수익:
$2.22M
순이익/손실:
$-40.51M
주가수익비율:
-12.85
EPS:
-1.2847
순현금흐름:
$-46.53M
1주 성능:
+7.90%
1개월 성능:
+50.46%
6개월 성능:
+108.59%
1년 성능:
+0.00%
1일 변동 폭
$16.08
$17.57
1주일 범위
$14.21
$17.57
52주 변동 폭
$5.14
$29.46
Upstream Bio Inc Stock (UPB) Company Profile
명칭
Upstream Bio Inc
전화
781-208-2466
주소
890 WINTER STREET, SUITE 200, WALTHAM
UPB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
UPB
Upstream Bio Inc
|
16.48 | 833.80M | 2.22M | -40.51M | -46.53M | -1.2847 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.92 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.06 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
672.75 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
296.29 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Upstream Bio Inc Stock (UPB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-05 | 개시 | JP Morgan | Overweight |
| 2024-11-05 | 개시 | Piper Sandler | Overweight |
| 2024-11-05 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 개시 | William Blair | Outperform |
Upstream Bio Inc 주식(UPB)의 최신 뉴스
Upstream Bio, Inc. Reports Increased R&D Investments - TipRanks
Building trade automation scripts for Upstream Bio Inc.High Yield Watchlist with Filtered Picks - Newser
Upstream Bio (UPB) Q2 R&D Soars 169% - AOL.com
Is it too late to sell Upstream Bio Inc.Low Risk Strategy with Smart Entry Zones - Newser
Key resistance and support levels for Upstream Bio Inc.Free Swing Trade With Risk Management - Newser
Positive Outlook for Upstream Bio, Inc. Driven by Promising Clinical Trial Developments - TipRanks
Optimistic Buy Rating for Upstream Bio, Inc. Driven by Promising Lead Asset and Strong Execution - TipRanks
Upstream Bio's Q2 2025: Can a Robust Cash Position and TSLP Pipeline Sustain Investor Optimism Amid Rising Burn Rates? - AInvest
Upstream Bio Q2 Net Loss Narrows, Revenue Rises - MarketScreener
Upstream Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Upstream Bio's Strategic Momentum in TSLP Inhibition: A Pathway to Redefining Respiratory Disease Treatment? - AInvest
Earnings Flash (UPB) Upstream Bio Posts Q2 Net Loss $0.74 a Share, vs. FactSet Est of $0.61 Loss - MarketScreener
Upstream Bio reports Q2 revenue $937k, consensus $317k - TipRanks
Upstream Bio Reports Second Quarter 2025 Financial Results and Highlights Continued Progress - GlobeNewswire
Tools to monitor Upstream Bio Inc. recovery probabilityFree Weekly Chart Analysis With Entry Advice - Newser
Real time social sentiment graph for Upstream Bio Inc.Summary of Consistent Growth Stock Picks - Newser
Comparing Upstream Bio Inc. in custom built stock radarsBear Market Safe Zone Technical Analysis - Newser
Analyzing net buyer seller activity in Upstream Bio Inc.Daily Technical Chart Pattern Analysis Report - Newser
Upstream Bio Inc. stock momentum explainedFree Price Action Based Buy Opportunity List - Newser
How to use a screener to detect Upstream Bio Inc. breakoutsProfit Target Planning with Exit Confidence - Newser
When is Upstream Bio Inc. stock expected to show significant growthUnbelievable profit margins - Jammu Links News
What are analysts’ price targets for Upstream Bio Inc. in the next 12 monthsCapitalize on emerging investment opportunities - Jammu Links News
What are Upstream Bio Inc. company’s key revenue driversAchieve rapid capital gains with smart investing - Jammu Links News
Is Upstream Bio Inc. stock overvalued or undervaluedCapitalize on emerging market sectors - Jammu Links News
Upstream Bio (UPB) Expected to Announce Earnings on Tuesday - Defense World
Why is Upstream Bio Inc. stock attracting strong analyst attentionMaximize gains with data-driven stock picks - Jammu Links News
Should I hold or sell Upstream Bio Inc. stock in 2025Tremendous return on equity - Jammu Links News
How does Upstream Bio Inc. compare to its industry peersTrack stocks with high upside potential easily - Jammu Links News
Is it the right time to buy Upstream Bio Inc. stockConsistent high-performance stocks - Jammu Links News
What drives Upstream Bio Inc. stock priceDynamic profit expansion - Jammu Links News
What is the risk reward ratio of investing in Upstream Bio Inc. stockGet timely advice on market trends - Jammu Links News
How many analysts rate Upstream Bio Inc. as a “Buy”AI Powered Review For 2025 - Jammu Links News
Does Upstream Bio Inc. stock perform well during market downturnsBest Dividend Picks For 2025 - Jammu Links News
Upstream Bio, Inc. shares rise 7.97% premarket after Arkema reported resilient EBITDA margin and solid cash generation. - AInvest
Can swing trading help recover from Upstream Bio Inc. lossesWeekly Trend Screener with Momentum Picks - Newser
How to manage a losing position in Upstream Bio Inc.Strategy Chart for Real-Time Trade Flow - Newser
What makes Upstream Bio Inc. stock price move sharplyFree Pattern Detection for Entry Confirmation - Newser
Exit strategy if you’re trapped in Upstream Bio Inc.AI Trend Detection for Entry Timing - Newser
Positive Outlook for Upstream Bio, Inc. Driven by Promising Phase II Study of Verekitug in CRSwNP Treatment - TipRanks
Upstream Bio Inc (UPB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Upstream Bio Inc 주식 (UPB) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | Director |
Oct 15 '24 |
Buy |
17.00 |
825,000 |
14,025,000 |
4,554,873 |
| AI Upstream LLC | 10% Owner |
Oct 15 '24 |
Buy |
17.00 |
1,175,000 |
19,975,000 |
1,175,000 |
0.43%
1.83%
자본화:
|
볼륨(24시간):